Aurobindo Pharma has informed that the officials of the Company will be participating in the investor meeting arranged by Motilal Oswal on 20th August 2024 at 08:00 am to 08:00 pm (IST) (In-person and Group meetings) in Mumbai. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.